Cardiovascular screening and the elite athlete: Advances, concepts, controversies, and a view of the future

Clinics in Sports Medicine

Volumn 30, Issue 3, 2011, Pages 503-524

  Battle, Robert W ^a   Mistry, Dilaawar J ^a   Malhotra, Rohit ^a   MacKnight, John M ^a   Saliba, Ethan N ^a,b   Mahapatra, Srijoy ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Athletic heart; Athletic sudden death; Cardiovascular screening; Elite athletes; Hypertrophic cardiomyopathy

Indexed keywords

AMPHETAMINE DERIVATIVE; DEXAMPHETAMINE;

AORTA COARCTATION; AORTA STENOSIS; AORTA VALVE REGURGITATION; ATHLETE; ATTENTION DEFICIT DISORDER; AUTOSOMAL DOMINANT DISORDER; BICUSPID AORTIC VALVE; BRUGADA SYNDROME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SYSTEM; CLINICAL EVALUATION; COMPETITION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONGENITAL HEART DISEASE; CORONARY ARTERY ANOMALY; EHLERS DANLOS SYNDROME; ELECTROCARDIOGRAM; ETHNICITY; EXERCISE TEST; GENETIC SCREENING; HEART ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; LOEYS DIETZ SYNDROME; LONG QT SYNDROME; MARFAN SYNDROME; MEDICAL HISTORY; MYOCARDITIS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PULMONARY HYPERTENSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SEX RATIO; SHORT QT SYNDROME; SOCIAL PARTICIPATION; SPORT; STANDARD; SUDDEN DEATH; TRANSTHORACIC ECHOCARDIOGRAPHY; WOLFF PARKINSON WHITE SYNDROME;

ATHLETES; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS; MASS SCREENING;

EID: 79958080418     PISSN: 02785919     EISSN: 1556228X     Source Type: Journal    
DOI: 10.1016/j.csm.2011.03.001     Document Type: Review

References (68)

1. Sweet W.E. Sport and recreation in ancient Greece 1987, Oxford University Press, New York.
2. Official 1990 NCAA basketball records 1991, 152-153. NCAA, Overland Park (KS). M. Pond (Ed.).
3. Maron B. Sudden death in young athletes: lessons from the Hank Gathers affair. N Engl J Med 1993, 329:55-57.
4. Maron B.J. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodeling: clinical significance, diagnostic strategies and implications for pre-participation screening. Br J Sports Med 2009, 43:649-666.
5. Hicky G., Fricker P. Attention deficit hyperactivity disorder, CNS stimulants and sport. Sports Med 1999, 27(1):11-21.
6. Maron B.J., Epstein S.E., Roberts W.C. Causes of sudden death in competitive athletes. J Am Coll Cardiol 1986, 7:204-214.
7. Roberts W.C. The congenitally bicuspid aortic valve: a study of 85 autopsy cases. Am J Cardiol 1970, 26:72.
8. Nitri S., Sorbo M.D., Mari M., et al. Aortic root dilation in young men with normally functioning bicuspid aortic valves. Heart 1999, 82:19.
9. Biner S., Rafique A.M., Ray I., et al. Aortopathy is prevalent in relatives of bicuspid aortic valve patients. J Am Coll Cardiol 2009, 53:2288-2295.
10. Maron B.J., Gohman T.E., Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998, 32:1991-1994.
11. Frieldewald V.E., Maron B.J., Roberts W.C. The editor's round table: sudden cardiac death in athletes. Am J Cardiol 2007, 100:1451-1459.
12. Maron B.J., Thompson P.D., Puffer J.C., et al. Cardiovascular participating screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996, 94:850-856.
13. Maron B.T., Douglas P.S., Graham T.P., et al. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. 36th Bethesda conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. Circulation 2005, 85:1322-1326.
14. Maron B.J., Shirani J., Poliac L.C., et al. Sudden death in young competitive athletes: clinical demographic and pathological profiles. JAMA 1996, 276:199-204.
15. Loeys B.L., Schwarze U., Holm T., et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006, 355:788-798.
16. Pyeritz R.E. The Marfan syndrome in childhood: features, natural history and differential diagnosis. Prog Pediatr Cardiol 1996, 5:151-157.
17. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol 2003, 42:1687-1713.
18. Basso C., Maron B.J., Corrado D., et al. Clinical profile of the congenital coronary anomalies with origin from wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000, 35:1493-1501.
19. Pluim B.M., Zwinderman A.H., Van der Laarse A., et al. The athlete's heart: a meta-analysis of cardiac structure and function. Circulation 2000, 101:336-344.
20. Huston P., Puffer J.C., MacMillian R.W. The athletic heart syndrome. N Engl J Med 1985, 315:24-32.
21. Fagard R. Athlete's heart. Heart 2003, 89:1455-1461.
22. Oakley C.M. The electrocardiogram in the highly trained athlete. Cardiol Clin 1992, 10:295-302.
23. Barbier J., Ville N., Kervio K., et al. Sports-specific features of athlete's heart and their relation to echocardiographic parameters. Herz 2006, 31:531-543.
24. Bjornstad H., Storstein L., Meen H.D., et al. Electrocardiographic findings in athletic students and controls. Cardiology 1992, 79:290-305.
25. Storstein L., Bjornstad H., Hals O., et al. Electrocardiographic findings according to sex in athletes and controls. Cardiology 1991, 79:227-236.
26. Bjornstad H., Storstein L., Dyre Meen H., et al. Electrocardiographic findings according to level of fitness and sport activity. Cardiology 1993, 83:268-279.
27. Bjornstad H., Storstein L., Meen H.D., et al. Electrocardiographic findings of repolarization in athletic students and control subjects. Cardiology 1994, 84:51-60.
28. Corrado D., Pelliccia A., Heidbuchel H., et al. Recommendations for interpretation of the 12-lead electrocardiogram in the athlete. Eur Heart J 2010, 31:243-259.
29. Pellicia A., Maron B.J., Culasso F., et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000, 102:278-284.
30. Magalaski A., Maron B.J., Main M.L., et al. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol 2008, 51:2250-2255.
31. Basavarajaiah S., Boraita A., Whyte G., et al. Ethnic differences in left ventricular remodeling in highly-trained athletes: relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol 2008, 51:2256-2262.
32. Montgomery H.E., Clarkson P., Dollery C.M., et al. Association of angiotension-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997, 96:741-747.
33. Karjalainen J., Kujala U.M., Stolt A., et al. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol 1999, 34:494-499.
34. Rawlings J., Carre F., Dervio G., et al. Ethnic differences in physiological cardiac adaptations to intense physical exercise in highly trained female athletes. Circulation 2010, 121:1078-1085.
35. Corrado D., McKenna W.J. Appropriate interpretation of the athlete's electrocardiogram saves lives as well as money. Eur Heart J 2007, 28:1920-1922.
36. Pelliccia A., Culasso F., Di Paolo F., et al. Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participating cardiovascular screening. Eur Heart J 2007, 28:2006-2010.
37. Sharma S., Whyte G., Elliott P., et al. Electrocardiographic changes in 1000 highly trained junior elite athletes. Br J Sports Med 1999, 33:319-324.
38. Foote C.B., Michaud G.F. The athlete's electrocardiogram distinguishing normal from abnormal. Sudden cardiac death in the athlete 1998, 101-103. Futura Publishing, Armonk (NY). N.A. Estes, D.N. Salem, P.J. Wang (Eds.).
39. Wu J., Stork T.L., Perron A.D., et al. The athlete's electrocardiogram. Am J Emerg Med 2006, 24:77-86.
40. Holly R.G., Shaffrath J.D., Amsterdam E.A. Electrocardiographic alterations associated with the hearts of athletes. Sports Med 1998, 25:139-148.
41. Maron B.J., Seidman J.G., Seidman C.E. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 44:2125-2132.
42. Marcus F.I., McKenna W.J., Sherrill D., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010, 121:1533-1541.
43. Corrado D, Michieli P, Schiavon M, et al. Prevalence and clinical significance of right precordial T-wave inversion at electrocardiographic preparticipation screening: a prospective study on 3086 young competitive athletes. Circulation 2007;116:339 [abstract: 3392].
44. Papadakis M., Basavarajaiah S., Rawlins J., et al. Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes. Eur Heart J 2009, 30(14):1728-1735.
45. Myerburg R.J., Vetter V.L. Electrocardiograms should be included in pre-participation screening of athletes. Circulation 2007, 116:2616-2626.
46. Maron B.J. National electrocardiography screening for competitive athletes: feasible in the United States. Ann Intern Med 2010, 152:24-26.
47. Chaitman B.R. An electrocardiogram should not be included in routine pre-participation screening of young athletes. Circulation 2007, 116:2610-2614.
48. Corrado D., Basso C., Schiavon M., et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998, 339:364-369.
49. Corrado D., Pelliccia A., Bjornstad H.H., et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005, 26:516-524.
50. Corrado D., Basso C., Pavei A., et al. Trends in cardiovascular sudden death in young competitive athletes after implementation of a preparticipation screening program. J Am Med Assoc 2006, 296:1593-1601.
51. Sedehi D., Ashley E.A. Defining the limits of athlete's heart: implication for screening in diverse populations. Circulation 2010, 121:1066-1068.
52. Pellica A., Maron B.J., Spataro A., et al. The upper limit of physiological cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991, 324:295-301.
53. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002, 287:1308-1320.
54. Maron B.J., Pellica A. The heart of trained athletes: cardiac remodeling and the risk of sports, including sudden death. Circulation 2006, 114:1633-1644.
55. Harris K.M., Spirito P., Maron M.S., et al. Prevalence, clinical profile and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006, 114:216-225.
56. Lewis J.A., Spirito P., Pellica A., et al. Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing " athlete's heart" from hypertrophic cardiomyopathy. Br Heart J 1992, 68:296-300.
57. Vinereanu D., Florescu N., Schulthorpe N., et al. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 2001, 88:53-58.
58. Richers C., Wilke N.M., Jerosch-Herold M., et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855-861.
59. Maron B.J., Haas T.S., Lesser J.R. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy. Circulation 2007, 115:e627-e628.
60. Maron M.S., Maron B.J., Harrigan C., et al. Hypertrophic cardiomyopathy phenotype revisited at 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009, 54:220-228.
61. Pellica A., Maron B.J., Culasso F., et al. Athlete's heart in women: echocardiographic characterization of highly trained elite female athletes. JAMA 1996, 276:211-215.
62. Maron M.S., Appelbaum E., Harrigan C., et al. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 2008, 1:184-191.
63. Ho C.Y., Lopez B., Coelho-Filho O.R., et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010, 363:552-563.
64. Pelliccia A., Spataro A., Maron B.J. Prospective echocardiographic screening for coronary artery anomalies in 1,360 elite competitive athletes. Am J Cardiol 1993, 72:978-979.
65. Perloff J.K. Congenital heart disease in adults: a new cardiovascular subspecialty. Circulation 1991, 84:1881-1890.
66. Hutter A.M. Cardiovascular abnormalities in the athlete: role of the physician. J Am Coll Cardiol 1994, 24:851-853.
67. Maron B.J., Brown R.W., McGrew C.A., et al. Ethical, legal, and practical considerations affecting medical decision making in competitive athletes. J Am Coll Cardiol 1994, 24:854-861.
68. Wyman R.A., Chiury R.Y., Rahko P.S. The 5-minute screening echocardiogram. J Am Soc Echocardiogr 2008, 21:786-789.